One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Cancer caught in the crossfire
doi : 10.1016/S1470-2045(23)00536-3
Volume 24, Issue 11, November 2023, Page 1157
Pembrolizumab as a first-line treatment for advanced gastric cancer
Ian Chau
doi : 10.1016/S1470-2045(23)00526-0
Volume 24, Issue 11, November 2023, Pages 1158-1159
Lessons and opportunities from improved understanding of global lung cancer histological subtypes
Wendy A Cooper
doi : 10.1016/S1470-2045(23)00475-8
Volume 24, Issue 11, November 2023, Pages 1159-1161
PEMMELA: a promising regimen at the expense of toxicity
Samuel Smith, *Steven Kao
doi : 10.1016/S1470-2045(23)00512-0
Volume 24, Issue 11, November 2023, Pages 1161-1162
Driving two chimeric antigen receptors (CARs) in a row to reduce antigen escape in B-cell acute lymphocytic leukaemia
Regina M Myers, *Stephan A Grupp
doi : 10.1016/S1470-2045(23)00517-X
Volume 24, Issue 11, November 2023, Pages 1163-1164
Immunotherapy in renal cell carcinoma
*Vishal Navani, Daniel Y C Heng
doi : 10.1016/S1470-2045(23)00473-4
Volume 24, Issue 11, November 2023, Pages 1164-1166
Understanding cancer risk in patients at lower risk to improve early cancer diagnosis
*Yin Zhou, Fiona M Walter
doi : 10.1016/S1470-2045(23)00514-4
Volume 24, Issue 11, November 2023, Pages 1166-1167
Anti-ableist oncology care: ensuring equity for people with physical disabilities
*Sean R Smith, Cheri Blauwet, Thomas Peter Edward Wells
doi : 10.1016/S1470-2045(23)00406-0
Volume 24, Issue 11, November 2023, Pages 1168-1170
Correction to Lancet Oncology 2023; 24: 1029–41
doi : 10.1016/S1470-2045(23)00482-5
Volume 24, Issue 11, November 2023, Page e425
Congressional Black Caucus calls for US-wide menthol cigarette sales ban
Talha Khan Burki
doi : 10.1016/S1470-2045(23)00508-9
Volume 24, Issue 11, November 2023, Page 1171
UK and France form partnership to tackle greatest challenges in cancer
Emma Wilkinson
doi : 10.1016/S1470-2045(23)00509-0
Volume 24, Issue 11, November 2023, Page 1172
High air pollution levels in Bangladesh despite international funding
Manjulika Das
doi : 10.1016/S1470-2045(23)00518-1
Volume 24, Issue 11, November 2023, Page 1173
Pilot cancer programmes in Côte d'Ivoire, Kenya, and Zimbabwe
Munyaradzi Makoni
doi : 10.1016/S1470-2045(23)00519-3
Volume 24, Issue 11, November 2023, Page 1174
US FDA proposes stronger laboratory test oversight
Bryant Furlow
doi : 10.1016/S1470-2045(23)00527-2
Volume 24, Issue 11, November 2023, Page 1175
UK announces plan to increase legal age of buying tobacco by 1 year every year
Tony Kirby
doi : 10.1016/S1470-2045(23)00528-4
Volume 24, Issue 11, November 2023, Page 1176
Starving cancer and other dangerous dietary misconceptions
*David Robert Grimes, Elizabeth O’Riordan
doi : 10.1016/S1470-2045(23)00483-7
Volume 24, Issue 11, November 2023, Pages 1177-1178
Comedians stand up to cancer at the Edinburgh Fringe
Peter Ranscombe
doi : 10.1016/S1470-2045(23)00455-2
Volume 24, Issue 11, November 2023, Pages 1178-1180
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
Sun Young Rha, Do-Youn Oh, Patricio Ya?ez, Yuxian Bai, Min-Hee Ryu, Jeeyun Lee, Fernando Rivera, Gustavo Vasconcelos Alves, Marcelo Garrido, Kai-Keen Shiu, Manuel Gonz?lez Fern?ndez, Jin Li, Maeve A Lowery, Timuçin Cil, Felipe Melo Cruz, Shukui Qin, Suxia Luo, Hongming Pan, Zev A Wainberg, Lina Yin, Sonal Bordia, Pooja Bhagia, Lucjan S Wyrwicz, on behalf of the KEYNOTE-859 investigators*
doi : 10.1016/S1470-2045(23)00515-6
Volume 24, Issue 11, November 2023, Pages 1181-1195
Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study
Neil D Gross, David M Miller, Nikhil I Khushalani, Vasu Divi, Emily S Ruiz, Evan J Lipson, Friedegund Meier, Yungpo Bernard Su, Paul L Swiecicki, Jennifer Atlas, Jessica L Geiger, Axel Hauschild, Jennifer H Choe, Brett G M Hughes, Dirk Schadendorf, Vishal A Patel, Jade Homsi, Janis M Taube, Annette M Lim, Renata Ferrarotto, Suk-Young Yoo, Melissa Mathias, Hyunsil Han, Frank Seebach, Israel Lowy, Matthew G Fury, Danny Rischin
doi : 10.1016/S1470-2045(23)00459-X
Volume 24, Issue 11, November 2023, Pages 1196-1205
Global variations in lung cancer incidence by histological subtype in 2020: a population-based study
Yanting Zhang*, Salvatore Vaccarella*, Eileen Morgan, Mengmeng Li, Jaione Etxeberria, Eric Chokunonga, Shyam Shunker Manraj, Bakarou Kamate, Abidemi Omonisi, Freddie Bray
doi : 10.1016/S1470-2045(23)00444-8
Volume 24, Issue 11, November 2023, Pages 1206-1218
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study
Li-Anne H Douma, Ferry Lalezari, Vincent van der Noort, Jeltje F de Vries, Kim Monkhorst, Illaa Smesseim, Paul Baas, Bodien Schilder, Marrit Vermeulen, Jacobus A Burgers, Cornedine J de Gooijer
doi : 10.1016/S1470-2045(23)00446-1
Volume 24, Issue 11, November 2023, Pages 1219-1228
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study
Jing Pan*, Kaiting Tang*, Yuechen Luo*, Samuel Seery, Yue Tan, Biping Deng, Feng Liu, Xiuwen Xu, Zhuojun Ling, Weiliang Song, Jinlong Xu, Jiajia Duan, Zelin Wang, Chunyu Li, Kai Wang, Yibing Zhang, Xinjian Yu, Qinlong Zheng, Liping Zhao, Jiecheng Zhang, Alex H Chang, Xiaoming Feng*
doi : 10.1016/S1470-2045(23)00436-9
Volume 24, Issue 11, November 2023, Pages 1229-1241
Future cancer risk after urgent suspected cancer referral in England when cancer is not found: a national cohort study
Suzanne E Scott, Carolynn Gildea, Brian D Nicholson, Ruth E Evans, Jo Waller, Debs Smith, Arnie Purushotham, Thomas Round
doi : 10.1016/S1470-2045(23)00435-7
Volume 24, Issue 11, November 2023, Pages 1242-1251
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial
Marc-Oliver Grimm, Emilio Esteban, Philippe Barthélémy, Manuela Schmidinger, Jonas Busch, Bego?a P Valderrama, Natalie Charnley, Marc Schmitz, Ulrike Schumacher, Katharina Leucht, Susan Foller, Gustavo Baretton, Ignacio Duran, Guillermo de Velasco, Frank Priou, Pablo Maroto, Laurence Albiges, for the TITAN-RCC study group
doi : 10.1016/S1470-2045(23)00449-7
Volume 24, Issue 11, November 2023, Pages 1252-1265
Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Rahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, Vadim Koshkin, Rohit Bose, Jonathan Chou, Arpita Desai, Daniel Kwon, Samuel Kaushal, Lauren Trihy, Medini Rastogi, Robin Ippisch, Maya Aslam, Terence Friedlander, Felix Feng, David Oh, Alexander Cheung, Eric Small, Michael Evans, Lawrence Fong*, Thomas A Hope*
doi : 10.1016/S1470-2045(23)00451-5
Volume 24, Issue 11, November 2023, Pages 1266-1276
A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis
Amani Arthur*, Matthew R Orton*, Robby Emsley, Sharon Vit, Christian Kelly-Morland, Dirk Strauss, Jason Lunn, Simon Doran, Hafida Lmalem, Axelle Nzokirantevye, Saskia Litiere, Sylvie Bonvalot, Rick Haas, Alessandro Gronchi, Dirk Van Gestel, Anne Ducassou, Chandrajit P Raut, Pierre Meeus, Mateusz Spalek, Matthew Hatton, Cecile Le Pechoux, Khin Thway, Cyril Fisher, Robin Jones, Paul H Huang†, Christina Messiou
doi : 10.1016/S1470-2045(23)00462-X
Volume 24, Issue 11, November 2023, Pages 1277-1286
Effects of trauma history on cancer-related screening, diagnosis, and treatment
Deborah C Marshall, Lauren M Carney, Kristin Hsieh, Daniel R Dickstein, Margaret Downes, Advaita Chaudhari, Shauna McVorran, Guy H Montgomery, Julie B Schnur
doi : 10.1016/S1470-2045(23)00438-2
Volume 24, Issue 11, November 2023, Pages e426-e437
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
Philipp Karschnia, Marion Smits, Guido Reifenberger, Emilie Le Rhun, Benjamin M Ellingson, Norbert Galldiks, Michelle M Kim, Jason T Huse, Oliver Schnell, Patrick N Harter, Malte Mohme, Expert Rater Panel*, Louisa von Baumgarten, Nathalie L Albert, Raymond Y Huang, Minesh P Mehta, Martin van den Bent, Michael Weller, Michael A Vogelbaum, Susan M Chang, Mitchel S Berger, Joerg-Christian Tonn
doi : 10.1016/S1470-2045(23)00453-9
Volume 24, Issue 11, November 2023, Pages e438-e450
Retroperitoneal metastasis of breast cancer misdiagnosed as retroperitoneal fibrosis
Taro Horino
doi : 10.1016/S1470-2045(23)00414-X
Volume 24, Issue 11, November 2023, Page e451
